Prediction of irinotecan toxicity in metastatic colorectal cancer patients based on machine learning models with pharmacokinetic parameters.


Journal

Journal of pharmacological sciences
ISSN: 1347-8648
Titre abrégé: J Pharmacol Sci
Pays: Japan
ID NLM: 101167001

Informations de publication

Date de publication:
May 2019
Historique:
received: 18 12 2018
revised: 23 02 2019
accepted: 25 03 2019
pubmed: 21 5 2019
medline: 18 12 2019
entrez: 21 5 2019
Statut: ppublish

Résumé

Irinotecan (CPT-11) is a drug used against a wide variety of tumors, which can cause severe toxicity, possibly leading to the delay or suspension of the cycle, with the consequent impact on the prognosis of survival. The main goal of this work is to predict the toxicities derived from CPT-11 using artificial intelligence methods. The data for this study is conformed of 53 cycles of FOLFIRINOX, corresponding to patients with metastatic colorectal cancer. Supported by several demographic data, blood markers and pharmacokinetic parameters resulting from a non-compartmental pharmacokinetic study of CPT-11 and its metabolites (SN-38 and SN-38-G), we use machine learning techniques to predict high degrees of different toxicities (leukopenia, neutropenia and diarrhea) in new patients. We predict high degree of leukopenia with an accuracy of 76%, neutropenia with 75% and diarrhea with 91%. Among other variables, this study shows that the areas under the curve of CPT-11, SN-38 and SN-38-G play a relevant role in the prediction of the studied toxicities. The presented models allow to predict the degree of toxicity for each cycle of treatment according to the particularities of each patient.

Identifiants

pubmed: 31105026
pii: S1347-8613(19)31042-4
doi: 10.1016/j.jphs.2019.03.004
pii:
doi:

Substances chimiques

7-ethyl-10-hydroxycamptothecin beta-glucuronide 0
Glucuronates 0
Topoisomerase I Inhibitors 0
folfirinox 0
Oxaliplatin 04ZR38536J
Irinotecan 7673326042
Leucovorin Q573I9DVLP
Fluorouracil U3P01618RT
Camptothecin XT3Z54Z28A

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20-25

Informations de copyright

Copyright © 2019 The Authors. Production and hosting by Elsevier B.V. All rights reserved.

Auteurs

Esther Oyaga-Iriarte (E)

Pharmamodelling S.L., Pamplona, Spain. Electronic address: eoyaga@pharmamodelling.com.

Asier Insausti (A)

Pharmamodelling S.L., Pamplona, Spain.

Onintza Sayar (O)

Pharmamodelling S.L., Pamplona, Spain.

Azucena Aldaz (A)

Department of Hospital Pharmacy, Clínica Universidad de Navarra, Pío XII 36, Pamplona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH